The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?

Current Atherosclerosis Reports
Michael B ClearfieldAlesia Wagner

Abstract

Despite population-based improvements in cardiovascular risk factors, such as blood pressure, cholesterol and smoking, cardiovascular disease still remains the number-one cause of mortality in the United States. In 1989, Kaplan coined the term "Deadly Quartet" to represent a combination of risk factors that included upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension [Kaplan in Arch Int Med 7:1514-1520, 1989]. In 2002, the third report of the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III) essentially added low HDL-C criteria and renamed this the "metabolic syndrome." [The National Cholesterol Education Program (NCEP) in JAMA 285:2486-2497, 2001] However, often forgotten was that a pro-inflammatory state and pro-thrombotic state were also considered components of the syndrome, albeit the panel did not find enough evidence at the time to recommend routine screening for these risk factors [The National Cholesterol Education Program (NCEP) in JAMA 285:2486-2497, 2001]. Now over a decade later, it may be time to reconsider this deadly quartet by reevaluating the roles of obesity and subclinical inflammation as they relate to the metabolic syndrome. To complete this new quartet,...Continue Reading

References

May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Apr 30, 2003·Diabetes·Charles M AlexanderUNKNOWN National Cholesterol Education Program (NCEP)
Nov 19, 2003·Annals of Internal Medicine·Tracey McLaughlinGerald Reaven
Mar 27, 2004·Experimental Biology and Medicine·Hirohisa TakanoToshikazu Yoshikawa
Apr 27, 2004·Journal of Applied Physiology·William D Bennett, Kirby L Zeman
Jun 3, 2004·Journal of the American College of Cardiology·James H O'KeefeRobert Vogel
Dec 20, 2005·The American Journal of Cardiology·Michael ClearfieldAntonio M Gotto
Jul 18, 2006·International Journal of Epidemiology·Ariana ZekaJoel Schwartz
Feb 3, 2007·The New England Journal of Medicine·Kristin A MillerJoel D Kaufman
Oct 11, 2007·European Journal of Endocrinology·Ram Weiss
Mar 11, 2008·Preventive Medicine·Siobhan HicklingJohn Beilby
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Dec 6, 2008·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·G Egger, J Dixon
Oct 1, 2009·Clinical Cornerstone·George A BrayDonald S Nelinson
May 7, 2010·The New England Journal of Medicine·Howard K Koh
May 12, 2010·Circulation·Robert D BrookUNKNOWN American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Coun
Jun 12, 2010·Journal of the American College of Cardiology·Ozgur BayturanSteven E Nissen
Sep 8, 2010·The New England Journal of Medicine·W Philip T JamesUNKNOWN SCOUT Investigators
Sep 25, 2010·Journal of the American College of Cardiology·Salvatore MottilloMark J Eisenberg
Oct 22, 2010·Environmental Health Perspectives·Jason D SacksMary Ross
Nov 23, 2010·Journal of the American College of Cardiology·Marcus BauerUNKNOWN HNR Study Investigative Group
Nov 23, 2010·Journal of the American College of Cardiology·Joel D Kaufman
Mar 12, 2011·Journal of Clinical Lipidology·James D OtvosDavid C Goff

❮ Previous
Next ❯

Citations

Mar 26, 2014·American Journal of Reproductive Immunology : AJRI·Joanne Kwak-KimAlice Gilman-Sachs
Jul 12, 2017·World Journal of Diabetes·Nyo Nyo TunJoseph M Pappachan
Nov 7, 2018·The Journal of the American Osteopathic Association·Michael ClearfieldJay H Shubrook
Sep 25, 2015·The Journal of Clinical Endocrinology and Metabolism·Scott AhlSrividya Kidambi
Nov 5, 2020·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Yinghui JiaoLili Wu
Aug 8, 2021·International Journal of Environmental Research and Public Health·Ruth McDermott-LevyCaroline H Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.